1Katz PO, Anderson C, Khoury R, Castell DO. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors. Aliment Pharmacol Ther, 1998, 12: 1231～1234.
2Ours TM, Fackler WK, Richter JE, Vaezi MF.Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol, 2003, 98: 545～550.
3Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology, 1996, 111: 1192～1199.
4Rodriguez-Stanley S, Robinson M, Earnest DL,Greenwood-Van Meerveld B, Miner PB Jr. Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol, 1999, 94: 628～631.
5Robinson M, Lanza F, Avner D, Haber M. Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. A randomized, doubleblind, placebo-controlled trial. Ann Intern Med,1996, 124: 859～867.
7Hetzel DJ, Dent J, Reed WD, Narielvala FM,Mackinnon M, McCarthy JH, Mitchell B, Beveridge BR, Laurence BH, Gibson GG, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology,1988, 95: 903～912.
8Vigneri S, Termini R, Leandro G, Badalamenti S,Pantalena M, Savarino V, Di Mario F, Battaglia G, Mela GS, Pilotto A, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med, 1995, 333: 1106～1110.
9Bardhan KD,GB, Muller-Lissner S,Bigard MA,Porro GB,Ponce J,Hosie J,Scott M,Weir DG,Gillon KR, Peacock RA,Fulton C.Symptomatic gastrooesophageal reflux disease:double blind controlled study of intermittent treatment with omeprazole or ranitidine.The European Study Group.BMJ,1999,318:502～507.
10Field SK, Gelfand GA, McFadden SD. The effects of antireflux surgery on asthmatics with gastroesophageal reflux. Chest, 1999, 116: 766～774.
